About HanBio

HanBio is a South Korean biotechnology company advancing cell-based platforms for regenerative health, hair biology, immune care, and cell banking.

Founded in 2019, HanBio has developed integrated capabilities across NK cells, stem cells, and dermal papilla cells. The company’s business foundation includes cell banking, cell culture, cryopreservation, biotechnology products, and therapeutic development programs supported by proprietary patents and GMP-oriented manufacturing infrastructure.

Mission

To advance human health through safe, scalable, and scientifically grounded cell technology.

Vision

To become a global regenerative cell technology company connecting cell preservation, manufacturing, and next-generation therapeutic development.

Core Values

Scientific Integrity
We build from evidence, process discipline, and measurable quality.

Cell Technology Excellence
We focus on isolation, expansion, preservation, and functionality.

Global Collaboration
We work with medical, research, commercial, and investment partners to expand access to advanced cell platforms.

Future-Ready Healthcare
We believe cell science will play a major role in the future of prevention, regeneration, and personalized care.